Systemic saturated lysophosphatidylcholine is associated with hepatic function in patients with liver cirrhosis.

Krautbauer, Sabrina; Eisinger, Kristina; Wiest, Reiner; Liebisch, Gerhard; Buechler, Christa (2016). Systemic saturated lysophosphatidylcholine is associated with hepatic function in patients with liver cirrhosis. Prostaglandins & other lipid mediators, 124, pp. 27-33. Elsevier 10.1016/j.prostaglandins.2016.06.001

[img] Text
Systemic saturated lysophosphatidylcholine is associated with.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.
Download (1MB)

Serum lysophosphatidylcholine (LPC) is described to decline in patients with chronic liver diseases. Here it was evaluated which of the LPC species are associated with liver function. LPC species were quantified by direct flow-injection electrospray ionization tandem mass spectrometry in serum of 45 patients with mainly alcoholic liver cirrhosis. Saturated LPC is 52.1 (31.7-110.0) μmol/l in serum of patients with CHILD-PUGH score C (decompensated liver cirrhosis) and significantly lower compared to patients with well-compensated disease (CHILD-PUGH score A) with 114.1 (12.3-401.4) μmol/l. Mono- and polyunsaturated LPC are not changed in these groups. Saturated LPC is negatively correlated with the model for end-stage liver disease score, bilirubin and galectin-3 and positively with Quick prothrombin time. Ascites and varices are complications of liver cirrhosis. Saturated LPC does, however, not correlate with hepatic venous pressure gradient, ascites volume and variceal size. Unexpectedly, saturated LPC measured in serum of 42 patients declines from 88.4 (27.8-177.5) μmol/l to 72.4 (27.6-141.8) μmol/l shortly after transjugular intrahepatic portosystemic shunt implantation. Hepatic vein saturated LPC (82.3 (12.4-161.7) μmol/l) is higher than portal vein levels (78.8 (10.1-161.0) μmol/l) suggesting hepatic release of this lipid species. Current data demonstrate that systemic saturated LPC species are reduced in patients with decompensated liver cirrhosis and associated with mortality risk.

Item Type:

 Journal Article (Original Article)

Division/Institute:

 04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Gastroenterology
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Gastroenterologie / Mukosale Immunologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Gastroenterologie / Mukosale Immunologie

UniBE Contributor:

 Wiest, Reiner

Subjects:

 600 Technology > 610 Medicine & health

ISSN:

 1098-8823

Publisher:

 Elsevier

Language:

 English

Submitter:

 Lilian Karin Smith-Wirth

Date Deposited:

 03 May 2017 11:01

Last Modified:

 05 Dec 2022 15:02

Publisher DOI:

 10.1016/j.prostaglandins.2016.06.001

PubMed ID:

 27265202

Uncontrolled Keywords:

 Ascites; CHILD-PUGH score; Galectin-3; Phosphatidylcholine

BORIS DOI:

 10.7892/boris.94434

URI:

 https://boris.unibe.ch/id/eprint/94434

Actions (login required)

Edit item Edit item
Provide Feedback